CA Stock MarketDetailed Quotes

MDCX Medicus Pharma Ltd

Watchlist
  • 3.050
  • +0.430+16.41%
15min DelayMarket Closed Nov 26 16:00 ET
36.04MMarket Cap-878P/E (TTM)

Medicus Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
1,480.74%4.04M
342.82%1.78M
207.85%3.01M
1,079.95%2.13M
-16.42%226.81K
-1.27%255.69K
50.30%402.53K
-32.12%978.42K
180.27K
271.36K
Selling and administrative expenses
1,329.78%2.95M
331.91%1.44M
748.87%2.82M
2,208.60%2.09M
126.77%186.42K
182.34%206.12K
286.90%333.42K
28.69%332.03K
--90.64K
--82.21K
-General and administrative expense
1,329.78%2.95M
331.91%1.44M
748.87%2.82M
2,208.60%2.09M
126.77%186.42K
182.34%206.12K
286.90%333.42K
28.69%332.03K
--90.64K
--82.21K
Research and development costs
2,055.88%1.07M
357.78%316.39K
-70.05%193.58K
-61.51%34.5K
-78.64%40.4K
-73.34%49.58K
-61.95%69.11K
-45.38%646.38K
--89.63K
--189.15K
Depreciation amortization depletion
--26.04K
--26.04K
----
----
----
--0
--0
----
----
----
-Depreciation and amortization
--26.04K
--26.04K
----
----
----
--0
--0
----
----
----
Operating profit
-1,480.74%-4.04M
-342.82%-1.78M
-207.85%-3.01M
-1,079.95%-2.13M
16.42%-226.81K
1.27%-255.69K
-50.30%-402.53K
32.12%-978.42K
-180.27K
-271.36K
Net non-operating interest income (expenses)
77.12%-88.26K
97.31%-9.01K
-6.21%-1.17M
0
-60.60%-450.34K
-41.64%-385.79K
-46.63%-334.56K
-59.55%-1.1M
-321.33K
-280.41K
Non-operating interest expense
-63.52%88.26K
-95.28%9.01K
40.29%739.1K
--0
124.45%306.48K
88.26%241.92K
126.20%190.7K
356.50%526.83K
--177.47K
--136.55K
Total other finance cost
----
----
-25.00%431.59K
--0
0.00%143.86K
-0.00%143.86K
0.00%143.86K
0.00%575.45K
--143.86K
--143.86K
Other net income (expenses)
-769.93%-2.6M
-501.81%-720.8K
-1,494.44%-2.29M
1,301.82%152.81K
339.09%253.17K
404.44%388.31K
179.39K
163.98K
Gain on sale of security
----
----
427.53%670.1K
--0
61.08%264.12K
1,301.82%152.81K
339.09%253.17K
-365.78%-204.6K
---413.51K
--163.98K
Special income (charges)
----
----
--0
----
----
----
----
--592.9K
----
----
-Less:Other special charges
----
----
----
----
----
----
----
---592.9K
----
----
Other non-operating income (expenses)
----
----
---3.27M
---720.8K
---2.55M
----
----
----
----
----
Income before tax
-745.18%-4.13M
-270.21%-1.79M
-300.86%-6.78M
-783.84%-2.85M
-664.25%-2.96M
10.18%-488.67K
-10.40%-483.92K
17.66%-1.69M
-322.21K
-387.79K
Income tax
Earnings from equity interest net of tax
Net income
-745.18%-4.13M
-270.21%-1.79M
-300.86%-6.78M
-783.84%-2.85M
-664.25%-2.96M
10.18%-488.67K
-10.40%-483.92K
17.66%-1.69M
-322.21K
-387.79K
Net income continuous operations
-745.18%-4.13M
-270.21%-1.79M
-300.86%-6.78M
-783.84%-2.85M
-664.25%-2.96M
10.18%-488.67K
-10.40%-483.92K
17.66%-1.69M
---322.21K
---387.79K
Noncontrolling interests
Net income attributable to the company
-745.19%-4.13M
-270.21%-1.79M
-300.86%-6.78M
-783.84%-2.85M
-664.25%-2.96M
10.18%-488.67K
-10.40%-483.92K
17.66%-1.69M
-322.21K
-387.79K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-745.19%-4.13M
-270.21%-1.79M
-300.86%-6.78M
-783.84%-2.85M
-664.25%-2.96M
10.18%-488.67K
-10.40%-483.92K
17.66%-1.69M
-322.21K
-387.79K
Diluted earnings per share
-723.55%-0.5
-265.92%-0.22
-822.65%-1.94
-780.80%-0.3526
-664.26%-0.3682
10.18%-0.0607
-10.40%-0.0601
17.66%-0.2103
-0.04
-0.0482
Basic earnings per share
-723.55%-0.5
-265.92%-0.22
-822.65%-1.94
-780.80%-0.3526
-664.26%-0.3682
10.18%-0.0607
-10.40%-0.0601
17.66%-0.2103
-0.04
-0.0482
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unaudited
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 1,480.74%4.04M342.82%1.78M207.85%3.01M1,079.95%2.13M-16.42%226.81K-1.27%255.69K50.30%402.53K-32.12%978.42K180.27K271.36K
Selling and administrative expenses 1,329.78%2.95M331.91%1.44M748.87%2.82M2,208.60%2.09M126.77%186.42K182.34%206.12K286.90%333.42K28.69%332.03K--90.64K--82.21K
-General and administrative expense 1,329.78%2.95M331.91%1.44M748.87%2.82M2,208.60%2.09M126.77%186.42K182.34%206.12K286.90%333.42K28.69%332.03K--90.64K--82.21K
Research and development costs 2,055.88%1.07M357.78%316.39K-70.05%193.58K-61.51%34.5K-78.64%40.4K-73.34%49.58K-61.95%69.11K-45.38%646.38K--89.63K--189.15K
Depreciation amortization depletion --26.04K--26.04K--------------0--0------------
-Depreciation and amortization --26.04K--26.04K--------------0--0------------
Operating profit -1,480.74%-4.04M-342.82%-1.78M-207.85%-3.01M-1,079.95%-2.13M16.42%-226.81K1.27%-255.69K-50.30%-402.53K32.12%-978.42K-180.27K-271.36K
Net non-operating interest income (expenses) 77.12%-88.26K97.31%-9.01K-6.21%-1.17M0-60.60%-450.34K-41.64%-385.79K-46.63%-334.56K-59.55%-1.1M-321.33K-280.41K
Non-operating interest expense -63.52%88.26K-95.28%9.01K40.29%739.1K--0124.45%306.48K88.26%241.92K126.20%190.7K356.50%526.83K--177.47K--136.55K
Total other finance cost ---------25.00%431.59K--00.00%143.86K-0.00%143.86K0.00%143.86K0.00%575.45K--143.86K--143.86K
Other net income (expenses) -769.93%-2.6M-501.81%-720.8K-1,494.44%-2.29M1,301.82%152.81K339.09%253.17K404.44%388.31K179.39K163.98K
Gain on sale of security --------427.53%670.1K--061.08%264.12K1,301.82%152.81K339.09%253.17K-365.78%-204.6K---413.51K--163.98K
Special income (charges) ----------0------------------592.9K--------
-Less:Other special charges -------------------------------592.9K--------
Other non-operating income (expenses) -----------3.27M---720.8K---2.55M--------------------
Income before tax -745.18%-4.13M-270.21%-1.79M-300.86%-6.78M-783.84%-2.85M-664.25%-2.96M10.18%-488.67K-10.40%-483.92K17.66%-1.69M-322.21K-387.79K
Income tax
Earnings from equity interest net of tax
Net income -745.18%-4.13M-270.21%-1.79M-300.86%-6.78M-783.84%-2.85M-664.25%-2.96M10.18%-488.67K-10.40%-483.92K17.66%-1.69M-322.21K-387.79K
Net income continuous operations -745.18%-4.13M-270.21%-1.79M-300.86%-6.78M-783.84%-2.85M-664.25%-2.96M10.18%-488.67K-10.40%-483.92K17.66%-1.69M---322.21K---387.79K
Noncontrolling interests
Net income attributable to the company -745.19%-4.13M-270.21%-1.79M-300.86%-6.78M-783.84%-2.85M-664.25%-2.96M10.18%-488.67K-10.40%-483.92K17.66%-1.69M-322.21K-387.79K
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -745.19%-4.13M-270.21%-1.79M-300.86%-6.78M-783.84%-2.85M-664.25%-2.96M10.18%-488.67K-10.40%-483.92K17.66%-1.69M-322.21K-387.79K
Diluted earnings per share -723.55%-0.5-265.92%-0.22-822.65%-1.94-780.80%-0.3526-664.26%-0.368210.18%-0.0607-10.40%-0.060117.66%-0.2103-0.04-0.0482
Basic earnings per share -723.55%-0.5-265.92%-0.22-822.65%-1.94-780.80%-0.3526-664.26%-0.368210.18%-0.0607-10.40%-0.060117.66%-0.2103-0.04-0.0482
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unaudited--------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data